Clinical Scorecard: IFSLR 2025 Recap
At a Glance
| Category | Detail |
|---|
| Condition | Scleral Lens Research |
| Key Mechanisms | Physiological and pathological implications of scleral lens wear, study design, and regulatory compliance. |
| Target Population | Patients with irregular and regular refractive errors, dry eye disease, and advanced keratoconus. |
| Care Setting | Clinical research and specialty lens clinics. |
Key Highlights
- Importance of well-defined study objectives and rigorous study design.
- Challenges in patient recruitment and retention in diverse populations.
- Emerging evidence for scleral lenses in managing dry eye disease.
- Innovative instrumentation and technology in scleral lens research.
- Need for multidisciplinary collaboration and standardized outcome measures.
Guideline-Based Recommendations
Diagnosis
- Assess safety, visual outcomes, comfort, and usability in scleral lens studies.
Management
- Consider scleral lenses as a management option for dry eye disease.
Monitoring & Follow-up
- Utilize data safety monitoring boards for high-risk clinical trials.
Risks
- Transparent communication of risks and benefits to study participants.
Patient & Prescribing Data
Patients with dry eye disease and irregular corneal surfaces.
Scleral lenses may provide a protective fluid barrier but can present wetting challenges.
Clinical Best Practices
- Adhere to ethical guidelines and regulatory compliance in study protocols.
- Implement standardized methodologies for scleral lens fitting and outcomes assessment.
- Leverage digital outreach and patient advocacy for improved recruitment.
References
